NPM1 and acute myeloid leukemia: This variation of viability in control cultures did not show any significant associations with secondary versus de novo AML, differentiation (FAB classification, CD34 expression), genetic abnormalities (karyotype, NPM1 mutations, Flt3-ITD) or cytokine-dependent proliferation.